Header Logo

Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability.

Nayak S, Calvo JA, Cong K, Peng M, Berthiaume E, Jackson J, Zaino AM, Vindigni A, Hadden MK, Cantor SB. Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability. Sci Adv. 2020 06; 6(24):eaaz7808.

View in: PubMed